833P Mirvetuximab soravtansine (MIRV), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin (CARBO) and bevacizumab (BEV): Final results from a study in patients (pts) with recurrent platinum sensitive ovarian cancer
David M. O’Malley,Debra L. Richardson,I. Vergote,Lucy Gilbert,Cesar M. Castro,Diane Provencher,Ursula A. Matulonis,Gina Mantia-Smaldone,Lainie P. Martin,Patrick A. Zweidler‐McKay,Kathleen N. Moore
PDF的下载单位、IP信息已删除
(2025-6-4)
AllRightReserved
GingerF
HFH
帅气碧萱
1111
Ethan
Criminology34
无极微光
嘻嘻哈哈
贪玩的秋柔
张欢馨
yy
核桃
嘉心糖
朝阳区李知恩
初景
arbitmomo
愔愔
Hayat
fifteen
皖公网安备34019202002308
